ServiceNow Inc vs uniQure N.V. Ordinary Shares — how do they compare? ServiceNow Inc trades at $138.53 (market cap $143.30B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: ServiceNow Inc is far larger — about 96.8× uniQure N.V. Ordinary Shares's market cap, and ServiceNow Inc is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ServiceNow Inc for 54 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NOW | QURE | |
|---|---|---|
Market Cap | $143.30B | $1.48B |
Volume | 13,207,010 | 2,488,780 |
Sector | Technology | Health |
52-Week High | $189.26 | $70.59 |
52-Week Low | $83.00 | $9.03 |
Typical Hold Time | 54 Days | 0 Days |
Enterprise Value | $147.09B | $728.62M |
Signals from Pluang's Aura AI — not financial advice
ServiceNow (NOW) trades at $140.32, down 0.38% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $0.90, and its AI business surpassed $1 billion in annual contract value. Revenue grew to $13.28 billion in 2025, with a net income margin of 11.34%, though valuation multiples remain elevated with a P/E of 86.63.
The outlook is positive, supported by robust AI adoption and enterprise demand, but risks include high valuation, competitive pressures, and potential margin compression. Analysts are overwhelmingly bullish with an 86.96% buy rating and a consensus price target of $150.71, suggesting upside potential from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →